Literature DB >> 19155903

Patterns of change in uterine artery Doppler studies between 20 and 24 weeks of gestation and pregnancy outcomes.

Katie M Groom1, Robyn A North, Peter R Stone, Eliza H Y Chan, Rennae S Taylor, Gustaaf A Dekker, Lesley M E McCowan.   

Abstract

OBJECTIVES: To describe changes in mean uterine artery resistance index and bilateral notches between 20 and 24 weeks of gestation in healthy nulliparous women and to relate these changes to pregnancy outcome.
METHODS: A total of 2,189 nulliparous participants in the Screening for Pregnancy Endpoints study had pregnancy outcomes compared between four uterine artery Doppler groups: normal at 20 and 24 weeks of gestation (group 1), normal at 20 weeks and abnormal at 24 weeks (group 2), abnormal at 20 weeks and normal at 24 weeks (group 3), and abnormal at both 20 and 24 weeks (group 4). Abnormal uterine Doppler was defined as 1) mean resistance index greater than the 90th centile; 2) bilateral notches; and 3) a combination of 1, 2, or both. The main outcomes were preeclampsia and small for gestational age (SGA) neonates (less than the 10th customized centile).
RESULTS: Preeclampsia developed in 116 (5.3%) women, and 223 (10.2%) delivered SGA neonates. With abnormal Doppler defined as mean resistance index greater than the 90th centile, the rate of SGA increased across Doppler groups: group 1, 156 (8.4%); group 2, 13 (11%); group 3, 25 (19.5%); and group 4, 29 (35.4%) (P<.001). The rate of SGA was higher in group 3 compared with group 1. Preeclampsia differed among groups 1 (85 [4.6%]), 2 (9 [7.6%], 3 (7 [5.5%]), and 4 (15 [18.3%]) (P<.001).
CONCLUSION: Pregnancy outcomes in women with abnormal uterine artery Doppler results at either 20 or 24 weeks were intermediate between those with normal or abnormal results at both time points. If overall test performance could be enhanced by the addition of clinical data, biomarkers, or both, we would recommend that 20 weeks is the most appropriate gestation in the second trimester to perform uterine artery Doppler studies. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2009        PMID: 19155903     DOI: 10.1097/AOG.0b013e318195b223

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  Risk factors for preterm birth in an international prospective cohort of nulliparous women.

Authors:  Gustaaf Albert Dekker; Shalem Y Lee; Robyn A North; Lesley M McCowan; Nigel A B Simpson; Claire T Roberts
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

2.  Clinical risk prediction for pre-eclampsia in nulliparous women: development of model in international prospective cohort.

Authors:  Robyn A North; Lesley M E McCowan; Gustaaf A Dekker; Lucilla Poston; Eliza H Y Chan; Alistair W Stewart; Michael A Black; Rennae S Taylor; James J Walker; Philip N Baker; Louise C Kenny
Journal:  BMJ       Date:  2011-04-07

3.  Uterine vascular resistance and other maternal factors associated with the risk of developing hypertension during pregnancy.

Authors:  L A B Martins; E C A Veiga; C C C Ribeiro; V M F Simões; V C Cardoso; H Bettiol; M A Barbieri; R C Cavalli
Journal:  Braz J Med Biol Res       Date:  2020-11-18       Impact factor: 2.590

4.  Maternal folate, one-carbon metabolism and pregnancy outcomes.

Authors:  Tanja Jankovic-Karasoulos; Denise L Furness; Shalem Y Leemaqz; Gustaaf A Dekker; Luke E Grzeskowiak; Jessica A Grieger; Prabha H Andraweera; Dylan McCullough; Dale McAninch; Lesley M McCowan; Tina Bianco-Miotto; Claire T Roberts
Journal:  Matern Child Nutr       Date:  2020-07-28       Impact factor: 3.092

5.  Uterine artery Doppler study in second trimester of pregnancy.

Authors:  Olufemi Adebari Oloyede; Faye Iketubosin
Journal:  Pan Afr Med J       Date:  2013-07-05

6.  Clinical prediction in early pregnancy of infants small for gestational age by customised birthweight centiles: findings from a healthy nulliparous cohort.

Authors:  Lesley M E McCowan; John M D Thompson; Rennae S Taylor; Robyn A North; Lucilla Poston; Philip N Baker; Jenny Myers; Claire T Roberts; Gustaaf A Dekker; Nigel A B Simpson; James J Walker; Louise C Kenny
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.